// App-Quantinova.ai

OA0017 : Effects of subcutaneous C1‐esterase inhibitor on coagulation and fibrinolysis in patients with hereditary angioedema: Findings from the COMPACT And OLE study

Researchers

Presenter

  • Reshef A

Principal Investigators

  • Craig T

  • Longhurst H

  • Chiao J

  • Feuersenger H

  • Machnig T

  • Prusty S

  • Pragst I

Medical Centers

  • Barzilai Medical Center, Ashkelon, Israel

  • Penn State Hershey MedicalCenter, Hershey, United States

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • CSL Behring LLC, King of Prussia, Pennsylvania, United States

  • CSL Behring, Marburg, Germany

Locations

  • Israel

  • United States

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Hereditary angioedema

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Prostatic acid phosphatase

  • Prothrombin

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • Placebo Control

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved